Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 3.07 -0.07 (2.23%)
Previous Close $3.14    52 Week High
Open $3.15    52 Week Low
Day High $3.44    P/E N/A 
Day Low $2.94    EPS
Volume 1,281,676       

(NASDAQ: PLRZ) Delayed: 13.42 +0.19 (1.44%)
Previous Close $13.23    52 Week High
Open $13.52    52 Week Low
Day High $13.52    P/E N/A 
Day Low $12.50    EPS
Volume 66,731